15/03/2025 09:19 Senate averts government shutdown by passing federal funding ahead of midnight deadline
15/03/2025 09:19 Crew-10 astronauts lift off, finally on way to ISS
15/03/2025 09:19 Trump touts law-and-order vision, sounds off on past grievances with DOJ, FBI
15/03/2025 07:20 This Is the Only Thing Keith Richards Eats Before Rolling Stones Concerts
15/03/2025 07:20 I Found a Quick $10 Fix to Keep My Cheese Fresh for Weeks
15/03/2025 07:20 I Tried Taylor Swift’s Favorite Candy, and Now It’s My Favorite Candy Too
15/03/2025 05:19 Saudi Arabia’s role as Ukraine war mediator advances Gulf nation’s diplomatic rehabilitation − and boosts its chances of a seat at the table should Iran-US talks resume
15/03/2025 05:19 See you in the funny papers: How superhero comics tell the story of Jewish America
15/03/2025 05:19 A glimpse into a surreal abyss: how COVID ravaged a remote city in the Amazonian jungle – podcast
15/03/2025 03:20 Who’s Running the DOGE Wrecking Machine: The World’s Richest Man or a Little-Known Bureaucrat?

Study finds increased survival with nivolumab plus ipilimumab vs. chemo for metastatic colorectal cancer

Home » Business » Health » Study finds increased survival with nivolumab plus ipilimumab vs. chemo for metastatic colorectal cancer

Study finds increased survival with nivolumab plus ipilimumab vs. chemo for metastatic colorectal cancer

Lloyd Menjivar 10/12/2024 05:20

For patients with microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) metastatic colorectal cancer who had not previously received systemic treatment, progression-free survival is longer with nivolumab plus ipilimumab than with chemotherapy, according to a study published online in the Nov. 27 issue of the New England Journal of Medicine…

Medical Xpress
For patients with microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) metastatic colorectal cancer who had not previously received systemic treatment, progression-free survival is longer with nivolumab plus ipilimumab than with chemotherapy, according to a study published online in the Nov. 27 issue of the New England Journal of Medicine…
Read More